The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $2.97

Today's change-0.12 -3.88%
Updated April 29 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $2.97

Today's change-0.12 -3.88%
Updated April 29 4:00 PM -4GMT. Delayed by at least 15 minutes.

Harvard Bioscience Inc crosses below 125-day moving average

Harvard Bioscience Inc closed sharply lower Friday, dropping (U.S.)$0.12 or 3.88% to (U.S.)$2.97 and crossing below its 125-day moving average. Over the last five days, shares have lost 4.81% and are down 14.41% for the last year to date. This security has underperformed the S&P 500 by 47.69% during the last year.

Key company metrics

  • Open(U.S.) $3.06
  • Previous close(U.S.) $3.09
  • High(U.S.) $3.08
  • Low(U.S.) $2.83
  • Bid / Ask(U.S.) $0.00 / (U.S.) $3.35
  • YTD % change-14.41%
  • Volume154,623
  • Average volume (10-day)81,172
  • Average volume (1-month)74,560
  • Average volume (3-month)73,143
  • 52-week range(U.S.) $2.41 to (U.S.) $6.10
  • Beta1.06
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward15.23×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.06
Updated April 29 4:00 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue26292630
Total other revenue--------
Total revenue26292630
Gross profit12131114
Total cost of revenue14161417
Total operating expense27292728
Selling / general / administrative10101010
Research & development1222
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-10-12
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-10-21
Income after tax-10-10
Income tax, total0-101
Net income-10-10
Total adjustments to net income--------
Net income before extra. items-10-10
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10-10
Inc. avail. to common incl. extra. items-10-10
Diluted net income-10-10
Dilution adjustment00--0
Diluted weighted average shares34353332
Diluted EPS excluding extraordinary itemsvalue per share-0.020.01-0.040.00
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.020.01-0.040.00